In MS patients, ATX/LPA plasma measurements have been conflicting [17–21], complicated by treatment history, the timing of sample collection and the available control samples; however, ATX/LPA serum/plasma levels were found higher during relapses comparing to remissions, in the largest and more recent studies [19, 21]. Here, ENPP2 is linked to myeloid sarcoma.